M R21 Pill - white round
Pill with imprint M R21 is White, Round and has been identified as Repaglinide 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M R21
Repaglinide
- Imprint
- M R21
- Strength
- 0.5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
butylated hydroxyanisole,
silicon dioxide,
corn starch,
croscarmellose sodium,
calcium phosphate dibasic anhydrous,
magnesium stearate,
meglumine,
microcrystalline cellulose,
polacrilin potassium,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-3121 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0062 (Discontinued) | UDL Laboratories Inc. |
Related images for "M R21"
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.